BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38143380)

  • 1. A network pharmacology- and transcriptomics-based investigation reveals an inhibitory role of β-sitosterol in glioma via the EGFR/MAPK signaling pathway.
    Xie Y; Chen Z; Li S; Yan M; He W; Li L; Si J; Wang Y; Li X; Ma K
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):223-238. PubMed ID: 38143380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Sitosterol suppresses hepatocellular carcinoma growth and metastasis via FOXM1-regulated Wnt/β-catenin pathway.
    Chen Y; Yang Y; Wang N; Liu R; Wu Q; Pei H; Li W
    J Cell Mol Med; 2024 Feb; 28(3):e18072. PubMed ID: 38063438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol suppresses glioma progression and synergistically enhances the antitumor activity of gefitinib by inhibiting the EGFR/SRC/STAT3 signaling pathway.
    Zhou J; Liu Y; Chen J; Xiong N; Yi D
    Drug Dev Res; 2023 May; 84(3):592-610. PubMed ID: 36852868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
    Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
    [No Abstract]   [Full Text] [Related]  

  • 5. Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.
    Zhang P; Chen FZ; Jia QB; Hu DF
    IUBMB Life; 2019 Dec; 71(12):1857-1875. PubMed ID: 31381269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-375 regulates proliferation and apoptosis of glioma cancer cells by inhibiting CTGF-EGFR signaling pathway.
    Zhang LX; Jin W; Zheng J; Dai YX; Song Y; Ni HB; Jiang J; Liang WB
    Bratisl Lek Listy; 2018; 119(1):17-21. PubMed ID: 29405725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of AQP5 gene silencing on proliferation, migration and apoptosis of human glioma cells through regulating EGFR/ERK/ p38 MAPK signaling pathway.
    Yang J; Zhang JN; Chen WL; Wang GS; Mao Q; Li SQ; Xiong WH; Lin YY; Ge JW; Li XX; Gu Z; Zhao CR
    Oncotarget; 2017 Jun; 8(24):38444-38455. PubMed ID: 28404978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tropomyosin-like Meretrix meretrix Linnaeus polypeptide inhibits the proliferation and metastasis of glioma cells via microtubule polymerization and FAK/Akt/MMPs signaling.
    Fan Z; Xu Q; Wang C; Lin X; Zhang Q; Wu N
    Int J Biol Macromol; 2020 Feb; 145():154-164. PubMed ID: 31866539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
    Bao Z; Chen L; Guo S
    J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.
    Yang AL; Wu Q; Hu ZD; Wang SP; Tao YF; Wang AM; Sun YX; Li XL; Dai L; Zhang J
    Toxicol Appl Pharmacol; 2021 Nov; 431():115739. PubMed ID: 34619160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.
    Ye F; Gao Q; Xu T; Zeng L; Ou Y; Mao F; Wang H; He Y; Wang B; Yang Z; Guo D; Lei T
    J Neurooncol; 2009 Sep; 94(2):183-94. PubMed ID: 19300910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
    Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2351-2366. PubMed ID: 30225541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/β-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms.
    Gao L; Chen B; Li J; Yang F; Cen X; Liao Z; Long X
    PLoS One; 2017; 12(8):e0181346. PubMed ID: 28837560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibitor enhances cisplatin sensitivity of human glioma cells.
    Zhang Y; Xing X; Zhan H; Li Q; Fan Y; Zhan L; Yu Q; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):773-778. PubMed ID: 22173497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition.
    Chen Z; Zhang J; Xue H; Qian M; Guo X; Gao X; Xu J; Qi Y; Sun X; Li G
    Integr Cancer Ther; 2020; 19():1534735419900927. PubMed ID: 32129091
    [No Abstract]   [Full Text] [Related]  

  • 18. YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context.
    Jane EP; Premkumar DR; DiDomenico JD; Hu B; Cheng SY; Pollack IF
    Mol Cancer Ther; 2013 Mar; 12(3):326-38. PubMed ID: 23325792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.
    Zhang X; Song Q; Wei C; Qu J
    Cell Stress Chaperones; 2015 Jul; 20(4):631-41. PubMed ID: 25860915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
    Premkumar DR; Jane EP; Pollack IF
    Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.